Stocktoria

VIVOS INC RDGL

OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2001-08-08

VIVOS INC financials (annual, from 10-K)

Revenue
2016201720182019202020212022202320242025
Net income
2016201720182019202020212022202320242025
Free cash flow
2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$68,379$27,995$19,500$36,499$14,887$7,000$9,500$4,054
Gross profit-$59,755-$2,984-$6,036$7,720$2,887$1,392$3,472
R&D expense$352,232$324,629$732,698$343,802$286,848$84,668$67,584$104,208$203,037$328,026
Operating income-$3.2M-$2.6M-$2.8M-$2.5M-$2.5M-$672,521-$1.3M-$2.5M-$2.6M-$4.4M
Interest expense$25,375$287,471$261,374$5.6M$3.9M$6.3M
Income tax$0$0$0
Net income-$3.1M-$2.9M-$2.9M-$2.5M-$2.5M-$956,992-$1.6M-$7.7M-$6.4M-$9.9M
EPS (diluted)$-0.01$-0.01$-0.01$-0.01
Operating cash flow-$2.1M-$2.5M$2.5M$2.5M$2.5M$2.0M$2.3M$2.3M$1.5M-$1.9M
Free cash flow-$2.2M
Cash & equivalents$2.2M$1.6M$1.7M$1.6M$903,704$20,381$5,494$8,317$27,889
Inventory$57,257$8,475$0
Total assets$1.9M$2.2M$1.6M$1.7M$1.6M$937,539$43,873$16,486$15,697$41,996
Total liabilities$206,743$86,209$245,004$81,692$166,915$905,505$1.5M$958,660$4.3M$3.1M
Shareholders' equity$1.7M$2.1M$1.4M$1.7M$1.5M$32,034-$1.5M-$942,174-$4.3M-$3.0M

Growth · year-over-year · Revenue CAGR 49.7%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+144.3%+43.6%-46.6%+145.2%+112.7%-26.3%
Net income growth-258.1%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001449349 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.